These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 15206989)
1. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma. Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989 [TBL] [Abstract][Full Text] [Related]
2. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767 [TBL] [Abstract][Full Text] [Related]
3. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. Derom E; Louis R; Tiesler C; Engelstätter R; Kaufman JM; Joos GF Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
5. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study. Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141 [TBL] [Abstract][Full Text] [Related]
6. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma. Currie GP; Stenback S; Lipworth BJ Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770 [TBL] [Abstract][Full Text] [Related]
7. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma. Dahl R; Engelstätter R; Trebas-Pietraś E; Kuna P Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601 [TBL] [Abstract][Full Text] [Related]
8. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma. Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. Pedersen S; Garcia Garcia ML; Manjra A; Theron I; Engelstätter R Pediatr Pulmonol; 2006 Oct; 41(10):954-61. PubMed ID: 16868976 [TBL] [Abstract][Full Text] [Related]
10. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498 [TBL] [Abstract][Full Text] [Related]
11. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study. Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479 [TBL] [Abstract][Full Text] [Related]
12. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma. Boulet LP; Bateman ED; Voves R; Müller T; Wolf S; Engelstätter R Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of fluticasone and montelukast on allergen-induced asthma. Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327 [TBL] [Abstract][Full Text] [Related]
15. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients. Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. Nielsen LP; Dahl R Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. Xu J; Nave R; Lahu G; Derom E; Derendorf H J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524 [TBL] [Abstract][Full Text] [Related]
19. Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness. Langley SJ; Holden J; Derham A; Hedgeland P; Sharma RK; Woodcock A Chest; 2002 Sep; 122(3):806-11. PubMed ID: 12226017 [TBL] [Abstract][Full Text] [Related]
20. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]